| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 2 securities · passive | ||||||
|
TriSalus Life Sciences, Inc.
13G
TLSI · 89680M101
|
5.7% |
5/12/2026
Event 3/31/2026
|
||||
|
TriSalus Life Sciences Inc.
13G/A
TLSI · 89680M101
|
5.2% |
8/19/2025
Event 6/20/2025
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.